| Revenue | DKK -855K | +99% |
| EBITDA | DKK -1,8M | -2% |
| Net profit | DKK -3M | -81% |
| Total assets | DKK 3,3M | -11% |
| Equity | DKK -1,5M | -369% |
| Employees | 1 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -41 | -136 | -27 | -275 | -437 | -913 | -430 | -855 |
| Staff expenses | -0 | -0 | -0 | -123 | -1.291 | -2.482 | -1.306 | -916 |
| EBITDA | -41 | -136 | -27 | -398 | -1.728 | -3.395 | -1.737 | -1.771 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -155 | -350 | -386 |
| EBIT | -41 | -136 | -27 | -398 | -1.728 | -3.549 | -2.086 | -2.157 |
| Net financials | 1 | -3 | -3 | -2 | 48 | -20 | -66 | -118 |
| Profit before tax | -40 | -139 | -30 | -400 | -1.680 | -3.569 | -2.152 | -2.275 |
| Tax | -9 | 9 | -0 | -0 | -502 | -785 | -474 | 758 |
| Net profit | -31 | -147 | -30 | -400 | -1.178 | -2.784 | -1.679 | -3.032 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 73 | 14 | 18 | 54 | 3.726 | 3.525 | 3.701 | 3.277 |
| Equity | 19 | -129 | -158 | -308 | 2.013 | 1.229 | 550 | -1.482 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 54 | 143 | 176 | 363 | 1.713 | 2.295 | 3.151 | 4.759 |
| Total debt | 54 | 143 | 176 | 363 | 1.713 | 2.295 | 3.151 | 4.759 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MK Management | Management | 2023 | — | — |
MT Management | Management | 2017 | — | — |
JC Management | Management | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Biowatch Holding ApS | Company | 100.0% | 100.0% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Martin Kremmer | Management | 0 companies |
| Mikkel Thykjær Jørgensen | Management | 0 companies |
| John Chuong Ly | Management | 0 companies |